These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 8775469

  • 1. Temporary resolution of obstructive jaundice during ursodeoxycholic acid therapy in a patient with primary sclerosing cholangitis and a dominant biliary stricture.
    Fracchia M, Soubrane O, Houssin D, Galatola G.
    Ital J Gastroenterol; 1995; 27(8):430-5. PubMed ID: 8775469
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.
    Linder S, Söderlund C.
    Hepatogastroenterology; 2001; 48(38):387-92. PubMed ID: 11379315
    [Abstract] [Full Text] [Related]

  • 8. The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid.
    Rudolph G, Kloeters-Plachky P, Rost D, Stiehl A.
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):487-91. PubMed ID: 17489059
    [Abstract] [Full Text] [Related]

  • 9. Treatment options for primary sclerosing cholangitis.
    Sinakos E, Lindor K.
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):473-88. PubMed ID: 20678020
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Prevention of clogging of biliary stents by administration of levofloxacin and ursodeoxycholic acid].
    Sciumè C, Geraci G, Pisello F, Facella T, Li Volsi F, Modica G.
    Chir Ital; 2004 Aug; 56(6):831-7. PubMed ID: 15771038
    [Abstract] [Full Text] [Related]

  • 12. Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis.
    Rost D, Rudolph G, Kloeters-Plachky P, Stiehl A.
    Hepatology; 2004 Sep; 40(3):693-8. PubMed ID: 15349909
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Primary sclerosing cholangitis.
    Zein CO, Lindor KD.
    Semin Gastrointest Dis; 2001 Apr; 12(2):103-12. PubMed ID: 11352117
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study.
    Olsson R, Boberg KM, de Muckadell OS, Lindgren S, Hultcrantz R, Folvik G, Bell H, Gangsøy-Kristiansen M, Matre J, Rydning A, Wikman O, Danielsson A, Sandberg-Gertzén H, Ung KA, Eriksson A, Lööf L, Prytz H, Marschall HU, Broomé U.
    Gastroenterology; 2005 Nov; 129(5):1464-72. PubMed ID: 16285948
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.